Cardiovascular Disease, Strategic Development


Sanofi-Aventis

in
Sanofi-Aventis planned to cut about a third of its sales representatives in France, or 700-800 jobs.

IDev Technologies Inc.

in

Medtronic

in
Medtronic plans to cut about 3% of its workforce, or 1,100 jobs, as part of a global realignment plan.

BioSeek Inc.

in
BioSeek Inc. announced that it has entered into a collaboration agreement with Merck KGaA., acting for its d

Medtronic Inc.

in

Cardiotech International Inc.

in
Cardiotech International Inc. announced that it has formed AdvanSource Biomaterials Corporation to conduct its business and align its name with its strategic focus.

Total SA

in
Total SA is still focused on its plans to sell its 13% stake in Sanofi-Aventis. The company however seems in no hurry as the Chairman Thierry Desmarest told a shareholders meeting, "The general feeling we have is that the market undervalues Sanofi so there is no reason to act in a hurry by selling." He added, "But our objective is not to keep the stake indefinitely.

Bioxel Pharma Inc.

in
Bioxel Pharma Inc. announced it has extended its marketing presence in Asia through the execution of letters of intent with two major Korean generic drug companies for docetaxel active pharmaceutical ingredients. Each of these companies achieves sales of over $1 billion on an annualized basis. The names of the companies and the terms of these agreements have not been disclosed for proprietary reasons.

ISIS Pharmaceuticals Inc.

in
 
ISIS Pharmaceuticals Inc. announced that Bristol-Myers Squibb Company has selected a compound from the companies' collaboration as a development candidate. As a result,Isis will receive a $2 million milestone payment.